Similar to CDDO-Me, EGCG attenuates immune cell infiltration by inhibiting p38 MAPK and NF-κB activity in an experimental autoimmune encephalitis model [11,12,13,14,15]. Here, NFKB1 is linked to autoimmune encephalitis.